Original filing (PDF)20250930221238NAL0005697331001

B&D PHARMA LLC

Name: B&D PHARMA LLC — B&D PHARMA LLC CASH BALANCE PENSION PLAN, Form 5500 (2024)
Creator: B&D PHARMA LLC

Form 5500-SF

FILING_RECEIVED

B&D PHARMA LLC CASH BALANCE PENSION PLAN

Defined-benefit pension plan

Active participants

Accounts w/ balance

—

Plan assets (EOY)

$659K

Net assets (EOY)

$659K

Plan health score

/ 100

Grade A

Top-tier plan health

Directional indicator from public Form 5500 data — compliance & integrity, total plan cost, participant health and vendor stack, benchmarked against same-size peers. Not a fiduciary tool. Based on 50% of scoring inputs for this filing.

Compliance & integrity

100

Total plan cost

n/a

Plan health

n/a

Vendor & structure

Decision-maker contacts

CFO / Head of HR / Benefits Manager — verified email + LinkedIn for B&D PHARMA LLC.

Plan sponsor

Name

B&D PHARMA LLC

EIN

87-3399581

Address

45 W. PLEASANT AVE. · MAYWOOD, NJ · 07607

Phone

(917) 939-9122

Industry

Wholesale Tradesee all

Plan administrator

Same as plan sponsor.

Plan characteristics

Plan number

002

Plan year

2024

Plan year begin

2024-01-01

Tax period

2024-12-31

Filed

2025-09-30

Pension benefit codes

1A · Pay-related DB formula

1C · Cash balance or similar hybrid DB

1I · Frozen plan — no new benefit accrual

3B · Covers self-employed individuals

3D · Pre-approved plan (master / prototype / VS)

Audit & trust (Schedule H)

Auditor

—

Trustee / custodian

—

Trustee phone

—

Service providers (Schedule C)

Small plans don't disclose service providers

Related plans

Similar-size Wholesale Trade plans

INTEGRATIVE PEPTIDES, LLC

INTEGRATIVE PEPTIDES, LLC DEFINED BENEFIT PLAN

$664K · 3 participants

PARAGON ENTERPRISES INC.

PARAGON ENTERPRISES INC 401(K) PROFIT SHARING PLAN & TRUST

$665K · 22 participants

EIKONIZO THERAPEUTICS, INC.

EIKONIZO THERAPEUTICS 401(K) PLAN

$651K · 7 participants

ABELDT GP, LLC

ABELDT GP, LLC RETIREMENT PLAN

$670K · 21 participants

H2 PHARMA LLC

H2-PHARMA LLC - 401K PLAN

$670K · 13 participants